We’re also asking: what part should AI play in this vision, if at all? Stay tuned for our upcoming report on AI and industrial policy, focused on Europe, in October: ainowinstitute.org/general/publ...
Artificial Intelligence occupies a curious space in European policy discussions. Its position as a laggard in the AI “race” has become a symbol for the continent’s real and perceived lack of competiti...
What kinds of investments in Europe’s digital infrastructure would best serve the public interest? Register to join this event at European Parliament, curated by @meredithmeredith.bsky.social@cristinacaffarra.bsky.social@francescabria.bsky.socialdigitalindependenceeu.wordpress.com
<strong>Toward European Digital Independence - 24th September 14.30-18.30</strong>
This report came together with rich expertise across domains. Leading off from a workshop facilitated by Alix Dunn and guided by our stellar advisory council @cmorten.bsky.social@heidykhlaaf.bsky.social, and Hannah Bloch-Wehba.
The recent Chevron and Loper-Bright cases mark an uncertain future for a key aspect of tech policy: the ability of regulatory agencies to do their job. Today we’re also publishing a piece from Dr. Reshma Remachandran delving into the implications of these rulings. ainowinstitute.org/spotlight/th...
On June 28, 2024, the U.S. Supreme Court issued its decision on the two enjoined cases, Loper Bright Enterprises v Raimondo and Relentless, Inc. v Department of Commerce (hereafter, referenced as “Lop...
We focus a lot on the risks of AI and a lot less on whether these systems even work as claimed. Evaluating AI safety and efficacy in tandem highlights the trade offs and is another key lesson from the FDA approach. ainowinstitute.org/publication/...
The most effective point of regulatory leverage? Before a product goes to market. Instead of trying to fix harms long after they’ve occurred, pre-market scrutiny offers the strongest incentives for firms to comply. ainowinstitute.org/publication/...
[NEW] AI is often compared to snake oil: the FDA played a key role in making medicines safe, effective and ensuring we know how they work. We can learn from where it’s worked - and where it’s fallen short. Read more here: ainowinstitute.org/lessons-from...
Our latest report identifies key insights for AI regulation across the development cycle, drawing on lessons from pharmaceutical regulation.
Yesterday @ambakak.bsky.socialainowinstitute.org/news/ai-now-...
AI Now Institute Co-Executive Director Amba Kak testified at a Senate Committee on Commerce, Science and Transportation Hearing on “The Need to Protect Americans’ Privacy and the AI Accelerant“. Read ...
We’re thrilled to welcome Heidy Khlaaf to AI Now, and to engage more deeply in critiques of military AI use. As our Principal Research Scientist, Heidy researches AI uses in safety-critical systems, with an emphasis on national security use cases. ainowinstitute.org/author/heidy